Immunotoxicity of PCBs (Aroclors) in relation to Great Lakes. by Tryphonas, H
Immunotoxicity of PCBs (Aroclors) in
Relation to Great Lakes
Helen Tryphonas
Bureau of Chemical Safety, Food Directorate, Health Canada, Ottawa,
Ontario, Canada
Polychlorinated biphenyls (PCBs) are among the most widespread environmental pollutants and a
prominent contaminant of the Great Lakes basin. Due to their resistance to biodegradation and
lipophilic properties, PCBs bioaccumulate in fish tissues and in fish-eating humans. PCBs are also
known to cross the placenta and to be excreted into the mother's milk, thus predisposing the
infant to potentially adverse health effects. For example, a higher incidence of bacterial infections
was reported for breast-fed infants born to mothers who consumed large amounts of Great
Lakes fish compared to the incidence in control infants whose mothers ingested low amounts of
fish. While data regarding the PCB-induced immunotoxic effects in humans are scarce, data
derived from the use of experimental animals, including nonhuman primates, indicate that the
immune system is a potential target for the immunotoxic effects of PCBs. Such studies have
used the commercially available PCB mixtures alone. However, PCBs have the potential of
partially antagonizing the effects of other structurally related compounds including the highly toxic
dioxins, which are also present in small amounts in the Great Lakes. Thus, to fully evaluate the
magnitude of the immunotoxic risk PCBs pose to humans, consideration should be given to
investigations in which the interactive effects of PCBs are combined with other contaminants
present in the Great Lakes. Environ Health Perspect 103(Suppl 9):35-46 (1995)
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Introduction
Commercial polychlorinated biphenyls
(PCBs) are ubiquitous chemical mixtures
containing many of the 209 possible con-
geners (1). Their widespread use for diverse
industrial purposes during the last 60 years
led to considerable contamination of most
ecosystems throughout the world (2,3).
Due to their resistance to decomposi-
tion in the natural environment, PCBs per-
sist in the environment and are able to
migrate widely through natural atmos-
pheric and water transport mechanisms.
Although PCBs are only slightly soluble in
water, they dissolve readily in oils and are
thus accumulated in the fatty tissues of
fish, birds, animals, and humans (4,5).
PCBs are one ofthe major contaminants of
the Great Lakes and surrounding streams.
Humans are exposed to the Great Lakes
contaminants through the consumption of
food, primarily fish, and the ingestion of
drinking water (6-8). It has been reported
that consumption of fish from Lake
Michigan correlated with PCB levels in
human maternal serum and milk (9).
These data suggested that certain popula-
tions, including people who fish, their fam-
ilies, and native Americans, who consume
large amounts ofGreat Lakes fish might be
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at risk for PCB-related health effects
(9,10). For example, epidemiologic studies
of Great Lakes fish-eating cohorts have
shown that breast-fed infants of mothers
who consumed high amounts offish had a
higher incidence of microbial infections
than breast-fed infants ofmothers who did
not eat fish (11,12).
In addition to these studies, there is evi-
dence which indicates that PCBs may
affect the survival of a variety of living
organisms such as birds (3), seals (13), and
beluga whales (Delphinapterus leucas) (13).
This has raised serious concerns among
government regulators and the public at
large regarding the safety of Great Lakes
water and fish. These concerns have been
addressed over the years by several regula-
tory agencies at national and international
levels, and guidelines have been issued
regarding safe levels of PCBs in the Great
Lakes water and fish (14-16). Such guide-
lines were based mainly on carcinogenicity
end points and have not taken into consid-
eration the potential adverse immunotoxic
effects ofPCBs. While the effects of PCBs
on the immune system ofhumans have not
been studied systematically, data derived
from studies whereby laboratory animals
and nonhuman primates were exposed to
PCBs indicate that the immune system is
perhaps the most sensitive target for PCB
induced toxicity (17-20).
The objective of this paper is to criti-
cally review the experimental and human
epidemiologic data regarding effects of
PCBs on the immune system to identify
any limitations inherent to the existing
immunotoxicity data and to suggest addi-
tional data requirements that might con-
tribute to the determination of the
magnitude of risk that PCBs, present in
the Great Lakes, pose to human health.
Mechanisms of
Immunotoxicity
The mechanism(s) by which PCBs induce
their immunotoxic effects has not been
completely elucidated. Extensive studies on
structure-receptor binding relationships,
structure-induction relationships, and struc-
ture-toxicity relationships revealed that sev-
eral PCBs may share a common mechanism
of action with other structurally related
halogenated aromatic hydrocarbons such as
the tetrachlorodibenzo-p-dioxins (TCDD)
and chlorodibenzofurans (CDF) (21).
Such studies demonstrated that some of
the immunotoxic effects for the dioxinlike
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PCB congeners depend on the presence of
the aromatic hydrocarbon (Ah) receptor,
which has been shown to regulate the syn-
thesis ofa variety ofproteins (21,22).The
presence ofthe Ah receptor in tissues and
the ability ofPCBs to bind to this receptor
is a prerequisite for the observed immuno-
toxic effects ofthe dioxinlike PCBs (22,23).
The affinity of PCBs for the Ah receptor
depends on their molecular conformation,
which is determined by the chlorine substi-
tution pattern (24). Thus, the binding
affinity to the Ah locus is found to be
greatest for the more toxic PCB congeners,
3,3',4,4'-tetra-, 3,3',4,4',5-penta-, and
3,3',4,4',5,5'-hexa-chlorobiphenyls (25).
With respect to immunotoxicity, it has
been shown that the coplanar 3,3',4,4'-
tetrachlorobiphenyl (TCB), which binds
the receptor with a relatively high affinity,
causes severe suppression of the humoral
antibody response in C57BI/6 (Ahb/Ahb)
mice but not in the genetically different
DBA/2 D2 (Ahd/Ahd) mice in which TCB
exhibits a lower binding affinity for the Ah
receptor (24). In contrast, the di-ortho-
substituted 2,2',5,5'-TCB, which is pre-
dominantly in a nonplanar configuration
has weak receptor-binding affinity, and
hence is not immunosuppressive in either
mouse strain (24).
Mechanisms other than those involving
the Ah receptor may be operable in some
of the PCB congener-induced immuno-
toxicity. Such effects are thought to be
mediated via metabolism to arene oxide
intermediates capable ofalkylating critical
cellular macromolecules to form poten-
tially toxic covalently bound substrate-
macromolecular adducts (26). Differences
in the mechanisms by which PCBs induce
immunotoxicity are significant when
attempts are made to calculate toxic
equivalency factors (TEFs) for PCBs (22).
AnimalStudies (Rodents, Rabbits,
GuineaPigs, andChickens)
The commercial PCB mixtures reaching
the environment may contain as many as
209 PCB congeners. Many of these mix-
tures have been synthesized in the labora-
tory and are readily available for research
purposes. Consequently, studies regarding
the immunomodulating properties of
PCBs have been carried out using commer-
cially available PCB mixtures. PCB mix-
tures are known by a variety oftrade names
depending on the country ofproduction:
Aroclor (United States), Phenochlor
(France), Clophen (Germany), Kanechlor
(Japan), Fenchlor (Italy), and Sovol
(Union of Soviet Socialist Republics).
Aroclors are identified by a four-digit num-
ber. The first two digits refer to the 12 car-
bon atoms and the last two digits refer to
the percent, by weight, ofchlorine in the
mixture. Thus, Aroclor 1260, contains
about 60% chlorine, while Aroclor 1254
contains about 54% chlorine (25).
Recent studies have demonstrated that
the immunologic response to sheep red
blood cells (SRBC) is a sensitive indicator
for predicting the immunotoxic potential
ofchemicals (27). This parameter has been
used to establish immunologic dose-re-
sponse relationships ofseveral Aroclors in
mice exposed to a single ip injection ofthe
PCB congeners (28). Such studies indi-
cated that the higher chlorinated PCB mix-
tures ofAroclors 1260, 1254, and 1248 are
more immunotoxic than the lower chlori-
nated Aroclors 1232, 1016, and 1242. At
the lowest dose, 50 mg/kg body weight
(bw), both Aroclor 1260 and 1254
significantly reduced the plaque forming
cell (PFC) response, whereas the lower
chlorinated Aroclors 1248, 1242, 1016,
and 1232 were significantly immunotoxic
only at levels higher than 50 mg/kg bw
(Aroclor 1248 at a dose of 150, and
Aroclor 1242, 1016 and 1232 at a dose of
450 mg/kg bw). The calculated ED50 val-
ues (mmol/kg bw) were as follows: Aroclor
1260>1254>1248>1242>1016 >1232
(28). Additional data in experimental ani-
mals confirmed these conclusions (14). A
review ofthe available data for each ofthe
commercially available PCB mixtures is
presented below.
Aroclor 1260. Limited information
exists on the potential immunomodulating
effects ofAroclor 1260 following oral or
dermal exposure (29-33). A dose level of
400 ppm ofAroclor 1260 administered in
feed for 60 days resulted in decreased spleen
weights and eventual mortality in chickens
(29), while a sublethal dose level of50 ppm
administered to female guinea pigs for 6
weeks resulted in profound depressive
effects on the function ofhumoral and cellu-
lar parameters of the immune system
including reduced antibody titers to tetanus
toxoid (tt) and decreased leukocyte and
lymphocyte counts in peripheral blood.
The observed effects were not related to
stress due to the release ofglucocorticos-
teroids by the adrenal glands but were
thought to be the result ofa direct effect of
PCBs on the immune system (30).
Similarly, in the study by Vos and de Roij
(31), dose levels of 10 and 50 ppm of
Aroclor 1260 were administered to guinea
pigs in the feed for 8 weeks; this resulted in
a number of immunomodulatory effects,
most ofwhich were not dose related. These
included a decrease in gamma globulin-
containing cells in popliteal lymph nodes
following stimulation ofthe foot pad with tt
in the 10- and 50-ppm groups; an increase
in the percent serum albumin in the tt-
stimulated and -unstimulated guinea pigs; a
decrease in percent gamma globulin at the
10 ppm group only; a decrease in cervical
lymph node weights in the 10-ppm group
only; and an increase in the mesenteric
lymph nodes at both levels. However, the
leukocyte counts were unaffected by the
PCB treatment.
The effects ofAroclor 1260 have also
been investigated by Vos and Beems (32)
and Vos and Notenboom-Ram (33) in
rabbits following dermal exposure. Jn these
studies, doses of 118 (32) or 120 mg/kg
bw/day (33) were applied to the skin of
female rabbits for 38 days or 28 days,
respectively. Unequivocal thymus atrophy
ofthe cortex was reported in both studies,
but conflicting results were obtained with
respect to histopathology of spleen and
lymph nodes, as well as effects on body
weights. Specifically, the 118-mg dose level
resulted in reduced germinal centers in the
spleen and lymph nodes and in decreased
body weights (32), while the 120 mg/kg
bw/day dose did not have any effect on
these parameters (33).
Aroclor 1254. In contrast to Aroclor
1260, the immunomodulating effects of
Aroclor 1254 have been studied in
rodents and in rabbits by a number of
investigators (34-45).
In the experiment by Wierda et al.
(34), Aroclor 1254 was injected into male
mice ip for 4 days at doses of 550, 250,
135, and 63 mg/kg bw/day; this resulted
in a decreased PFC response to SRBC and
in decreased blood leukocyte numbers at
550-, 250-, and 135-mg/kg bw/day doses
but not at 63 mg/kg bw/day; a decrease in
spleen cellularity was noted in all doses.
The concanavalin A-induced (ConA) and
lipopolysaccharide-induced (LPS) mito-
genic response of splenocytes was not
affected by treatment.
Smith et al. (35) studied the effects of
acute peroral (gavage) or subacute par-
enteral (sc injection for 14 days) exposure
ofadult and neonatal mice to Aroclor 1254
at doses of0.3 to 75 mg/kg bw and found
that the ability of mice to clear Listeria
monocytogenes from the circulation was
reduced in adult and neonatal males at the
0.3-mg/kg dose and in adult and neonatal
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females at the 75-mg/kg dose, indicating a
greater sensitivity to PCB treatment of
adult and neonatal males relative to that of
females. Similarly, an increased sensitivity
to Moloney leukemia virus was noted in
male mice fed 3.75, 37.5, or 375 ppm for
6 months (36).
The observed lower sensitivity of
female mice to Aroclor 1254 exposure was
also reported by Talcott and Koller (37).
In this study, doses of 1.17, 11.67, or 29.17
mg/kg bw/day (10, 100, or 250 ppm) of
Aroclor 1254 administered to female mice
in feed for 12 weeks did not have any
significant effect on body weights or anti-
body titers to bovine serum albumin
(BSA), phagocytosis measured by ingestion
of SRBC by peritoneal macrophages in
vitro, or delayed-type hypersensitivity to
Oxazolone. The only notable effect was a
decrease in spleen weights relative to body
weights at the 250 ppm dose level.
Exposure ofmale rats to Aroclor 1254
in feed also resulted in a number ofsignifi-
cant effects on humoral and cell-mediated
immune parameters. Talcott et al. (37,38)
and Exon (39) fed Aroclor 1254 at doses of
50 or 500 ppm to male rats for 10 weeks. A
decrease in serum immunoglobulin G (IgG)
antibody titers to keyhole limpet hemo-
cyanin (KLH) antigen was observed at both
dose levels, whereas the interleukin 2 (IL-2)
production by ConA-stimulated spleno-
cytes was increased at these levels. On the
contrary, IL-2 production by ConA-stimu-
lated splenocytes was decreased when cells
were exposed in vitro to 0.4 or 20 lig/ml of
Aroclor 1254 (38). The natural killer (NK)
cell activity was decreased at both dose levels
and in the in vitro exposure ofsplenocytes
to 0.4 or 20 pg/ml ofAroclor 1254 (38).
Depressed NK activity was also noted
by Smialowicz (40) following repeated
treatment with Aroclor 1254 at doses of 10
and 25 mg/kg bw/day administered to
male rats orally (gavage). Doses of0.1 or 1
mg/kg bw/day had no effect on NK cell
activity. The effect on NK cell activity by
the higher dose levels was accompanied by
decreased body and thymus weights.
Increased phytohemagglutinin (PHA) but
not ConA- , pokeweed mitogen (PWM)-,
or Salmonella typhimurium (STM)-mito-
gen-induced lymphocyte proliferation was
noted at the 25-mg/kg bw/day dose levels.
Similarly, increased PHA- but not PWM-
induced lymphoproliferative activity was
observed in male rats fed 1.88 mg/kg
diet/day (25 ppm) ofAroclor 1254 for 7
days (41). These results suggest thatAroclor
1254 affected a subset ofT-lymphocytes
rather than the B-lymphocytes. In contrast
to the increased sensitivity of male mice
and rats to Aroclor 1254, male rabbits
administered Aroclor 1254 at doses of
0.18, 0.92, 2.10, or 6.44 mg/kg diet/day
(3.7, 20.0, 45.8, or 170.0 ppm) for 8
weeks did not show any effect on antibody
levels to SRBC, the gamma globulin/trans-
ferrin ratio, or skin reactivity to tuberculin,
albeit thymus atrophy was observed across
all dose levels (42).
The role that Aroclor 1254 plays in
tumor development is not clear. Paradox-
ically, the available data reveal a protective
effect ofsublethal but immunotoxic doses
of this mixture. The experiments by
Kerkvliet and Kimedorf (43,44), whereby
the effect ofAroclor 1254 on the trans-
plantability and growth ofthe Walker 256
carcinosarcoma in rats was studied, showed
that growth ofthe tumor cells was retarded
in rats treated with single ip injections of
100 or 200 mg/kg bw compared to control
rats. Experiments were based on the
hypothesis that a suppressed immunologic
state in the host can enhance the genera-
tion and growth oftumors. At these dose
levels ofPCB, increased resistance to trans-
planted tumors, decreased metastases,
increased incidence of tumor regression,
and increased survival time of rats com-
pared to control (non-PCB-treated but
tumor-transplanted rats) were observed.
Lethality was observed in 9/16 rats only
after exposure to a high dose of400 mg/kg
bw ofAroclor 1254.
The protective effect ofsublethal levels
ofAroclor 1254 was also noted in groups
ofmice fed doses of 10, 50, or 250 ppm. A
decreased mortality rate compared to the
control group was observed in the PCB-
treated mice following injection with
Ehrlich's tumor ascites cells (45). Similarly,
BALB/c male mice fed Aroclor 1254 at
sublethal doses of 3.75 or 37.5 ppm for 6
months and subsequently injected with
Moloney leukemia virus did not differ in
the incidence and severity of hepatic
lesions from that in the control group,
while a high dose of 375 ppm resulted in
92% lethality and increased incidence and
severity ofhepatic lesions (36).
Aroclor 1248. Thomas and Hinsdill
(46) investigated Arodor 1248 at doses of
50, 100, 500, and 1000 ppm fed to female
mice for 3 to 5 weeks. The spleen and
thymus weights were not affected by treat-
ment. Resistance to S. typhimurium, exam-
ined only at 1000 ppm, was decreased
compared to the control group, and endo-
toxin sensitivity examined at 100 or 1000
ppm was increased over the control values.
The antibody response to SRBC examined
at the 1000-ppm dose was not affected
by treatment.
In subsequent studies, Thomas and
Hinsdill (47) investigated the effect of
Aroclor 1248 administered to adult female
rabbits (three animals per group) at levels
of 10, 100, or 250 ppm for 4 weeks. These
were mated and the offspring continued to
be exposed to PCBs in milk until theywere
weaned at 4 weeks of age. No effect was
noted in the adultweight gain, litter size, or
postnatal mortality. In offspring, weaned at
4 weeks ofage and tested at 7 weeks ofage,
contact sensitivity to dinitrofluorobenzene
was reduced only at the 250-ppm dose
level compared to controls. At that level,
the body weight of the exposed offspring
was lower than that ofthe control group,
making it difficult to determine whether
the observed effect on delayed-type hyper-
sensitivity was direct due to PCB treatment
orsecondary to some other form oftoxicity.
No treatment-related effect was detected
for the thymus and spleen weights, PFC
numbers, anti-SRBC antibody levels, or
the mitogen-stimulated lymphocyte prolif-
eration, indicating that the humoral and
cellular immune functions associated with
these parameters were not affected by the
PCB treatment.
Aroclor 1242. A single ip injection of
Aroclor 1242 at 1000 mg /kg bw to male
mice resulted in spleen enlargement with
decreased absolute lymphocyte counts. A
transiently increased graft-versus-host
(GVH) reaction was also observed in
treated mice compared to controls (48).
Functional studies using a single clini-
cally subtoxic dietary dose level of 167
ppm ofAroclor 1242 fed to male mice for
3 and 6 weeks showed a decrease in pri-
mary and secondary PFC responses to
SRBC with concomitant decreases in total
serum IgG1, IgA, and IgM without any
detectable effects on spleen and thymus
weights or histopathological changes in
the thymus, spleen, and mesenteric lymph
nodes (49-52). It is not clear from these
studies whether antibody memory cell
function was impaired or whether cell-cell
cooperation was affected. At the same
dose and length ofexposure, an increased
susceptibility to bacterial endotoxin
(Salmonella typhosa) and the malaria para-
site Plasmodium berghei was noted.
However, this dose level ofAroclor 1242
fed to male mice for 18 weeks did not have
any detectable effect on macrophage func-
tions such as oxygen consumption and
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phagocytic or microbiocidal activity (53).
Since macrophages play a crucial role in
combating infection, it is possible that
macrophage functions other that those
listed above may have been affected by the
treatment. In fact, RNA synthesis by
elicited mouse peritoneal macrophages
tested in vitro was inhibited by 22.6, 25.0,
or 28.3 pg/ml ofAroclor 1242; coincuba-
tion ofmacrophages with PCB dose levels
of1.0 or 7.25 pg/ml had no effect (54).
Like Aroclor 1254, doses of 5 or 100
ppm ofAroclor 1242 fed to mice for 3, 6,
or 18 weeks did not affect resistance to
tumor challenge by EL-4, MKSA, and
P388 tumors or tumoricidal activity ofthe
animals albeit cytotoxic activity of the
adherent spleen cells, which represent the
mononuclear phagocytic cells, was reduced
in mice fed the 13.17-mg/kg (100 ppm)
dose level (53).
Further studies in mice fed Aroclor
1242 at dose levels of37.5 or 375 ppm for
6 months and subsequently challenged
with Moloney leukemia virus resulted in
an increased incidence and severity of
hepatic lesions; a dietary dose level of3.75
ppm had comparable effects on hepatic
lesions to those observed in the control ani-
mals, which were challenged with Moloney
leukemia virus only without exposure to
Aroclor 1242 (36). In contrast to Aroclor
1242, Aroclor 1221 at dose levels of3.75,
37.5, or 375 ppm fed to mice for 6 months
produced hepatic lesions induced by
Moloney leukemia virus, which did not
differ in severity from those in the control
animals injected only with the Moloney
leukemia virus, confirming the compara-
tively lower toxicity ofAroclor 1221 (36).
Finally, Allen and Abrahamson (55)
reported that the body-weight gain, thymus
weight, and the white blood cell (WBC)
and neutrophil counts were decreased in
Sprague-Dawley rats fed Aroclor 1248,
1254, and 1262 for 1, 4, and 6 weeks at a
level of 0.1% of the diet; the degree of
severity was 1248> 1254> 1262. No effect
was noted on spleen weights; however,
functional aspects ofthe immune system
were not investigated.
Aroclor 1016. As predicted from the
studies of Davis and Safe (28), Aroclor
1016 was not found to be immunotoxic at
doses below 450 mg/kg. A dose level of
167 ppm fed to male mice for 40 weeks did
not produce any effects on spleen and thy-
mus weights, the GVH reaction, the mixed
lymphocyte response, the mitogen-induced
lymphocyte proliferation ofsplenocytes, or
the cytotoxicity of splenocytes (56).
However, the effects ofAroclor 1016 on
humoral immunity were not investigated
in this study.
Clophen A60. Vos and van Driel-
Grootenhuis (30) investigated the effect of
Clophen A60 at dose levels of 10, 50, and
250 ppm fed daily to female guinea pigs
for 4 weeks. Eighty percent lethality was
observed at the 250 ppm dose. Skin reac-
tivity to tuberculin as well as antibody
titers (IgM and IgG) to tt were decreased
at a dose level as low as 50 ppm of PCBs.
Relative thymus weights and leukocyte and
lymphocyte counts were also decreased at
that level.
Kanechlor 500. Imanishi et al. (57)
reported that mice fed Kanechlor 500 at
doses of 200 or 400 ppm of feed for 21
days resulted in an increased mortality rate
in herpes simplex virus-infected mice. No
such effect was noted at 100 ppm. The
effects of Kanechlor 500 were also studied
in mice exposed as adults or in utero (58).
The adult female mice gavaged with 50
mg/kg bw 2 times/week for 3 weeks did
not exhibit any effects on body and spleen
weights, spleen cellularity, or the antidini-
trophenol (DNP)-IgM PFC numbers, but
a transient decrease in T-helper cell activity
in the secondary anti-DNP-IgG response
(adoptive cell transfer) was detected at 4
and 7 weeks but not at 11 weeks after
exposure. This effect was also noted in the
in utero-exposed offspring at 4 weeks but
not at 7 or 11 weeks after exposure.
Interaction ofPCBs inMixtui-es
Data regarding the effects of mixtures of
PCBs or of PCB interactions with other
chemicals on the immune system are scarce.
It has been reported that pretreatment
of C57BL/6 male mice with a single ip
dose of 550 mg/kg bw ofAroclor 1254-
ameliorated benzene induced leukopenia
and suppression of mitogen-induced
leukocyte proliferation (34). This was
attributed to the possible interference of
Aroclor 1254 with the production ofben-
zene metabolites because Aroclor 1254 has
been shown to decrease the covalent bind-
ing of benzene-associated radioactivity in
the liver and lymphoid organs ofrats (59).
Also, pretreatment with Aroclor has been
shown to decrease the amount ofthe ben-
zene metabolites hydroquinone and cate-
chol in the thymus, spleen, and bone
marrow of rats (60). However, Aroclor
1254 pretreatment did not substantially
alter the reduced PFC numbers induced by
either benzene or Aroclor 1254 treatment
alone (34).
Kunita et al. (61) administered to male
Sprague-Dawley rats the PCBs Kanechlor
400 at 1.0 mg, polychlorinated quater-
phenyls (PCQ) at 1.0 mg, polychlorinated
dibenzofurans (PCDF) at 10.0 pg/day, or a
mixture (Mix-1) ofthe above in feed for 22
days. Reduced anti-SRBC titers were noted
for Kanechlor 400, and PCDF with a fur-
ther reduction observed for the mixture,
suggesting that Kanechlor 400 and PCDF
had an additive effect for the suppression
ofantibody titers to SRBC. On the con-
trary, Davis and Safe (28) demonstrated
that various Aroclors had an antagonistic
effect on 2,3,7,8-TCDD immunotoxicity
measured by the PFC response to SRBC.
These studies demonstrated that Aroclor
1254 antagonized the effects of 2,3,7,8-
TCDD and that the degree ofantagonism
was similar for Aroclor 1260, 1254, and
1248, whereas Aroclor 1242 and 1232
(which bind the Ah receptor with low
affinity) had no antagonistic effect at the
doses used. The observed antagonistic
effect ofAroclors was thought to be related
to their ability to displace 2,3,7,8-TCDD
from the Ah receptor protein (62).
However, similar results were obtained
when 2,2',4,4',5,5'-hexachlorobiphenyl
and 2,3,7,8-TCDD were co-administered
to C57BL/6 mice (62), regardless of the
fact that 2,2',4,4',5,5'-hexachlorobiphenyl
does not cause responses that are mediated
through theAh receptor (63).
GreatLakes FishStudies
Great Lakes contaminants have been
shown to bioaccumulate within the food
chain especially in aquatic organisms, in
several species offish-eating birds (3), and
in humans mainly through consumption of
fish (9). The toxic effects of Great Lakes
contaminants, including PCBs, on rats
were studied by Villeneuve et al. (8). In
this study, diets containing salmon from
Lake Ontario and the Pacific Ocean at
dietary levels of 1.25, 2.90, and 5.80%
were administered to Sprague-Dawley rats
in feed for 28 days. The PCB and organo-
chlorine insecticide contaminant levels in
Lake Ontario salmon were considerably
higher than in the Pacific salmon. Spleen
weights, bone marrow cellularity, and
hematological parameters were not affected
by treatment. The only notable effect was a
reduction in body-weight gain in the
treated groups compared to the control
group. However, when these dose levels of
fish were administered to rats for 13 weeks,
a decrease in spleen weights was observed
at a dose level of 1.45% in males only for
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the Lake Ontario salmon and at a dose
level of2.90% in males only for the Pacific
coho salmon. No effects were noted on
body weight, food consumption, bone
marrow cellularity, and hematology. A
decrease in bone marrow myeloid cells was
noted in male rats exposed to a dietary
level of2.90% ofsalmon administered for
13 weeks followed by 13 weeks on the con-
trol diet (reversibility study) (64). The
myeloid:erythroid ratio and the lympho-
cyte and monocyte numbers were decreased
for both sources ofsalmon, but in the male
rats only. A second study by Cleland et al.
(65) investigated the effect of a diet con-
taining 33% of Lake Ontario or Pacific
coho salmon on the immune system of
male mice fed for 2 to 4 months. A
decrease in the IgM, IgG, and IgA PFC
numbers was reported for Lake Ontario
coho salmon but not for the Pacific coho
salmon. Cytotoxic T-lymphocyte responses
decreased only at a ratio of 10:1 and not at
any other ratio. No effect was noted on the
lymphocyte subpopulations. The differ-
ences in effects ofsalmon are ascribable to
differences in PCB and other organo-
chlorine contaminant levels in the two
fish-containing diets.
A recently completed study in this
laboratory (manuscript in preparation)
investigated the effects ofdiet on two gen-
erations ofpups born to dams fed various
levels ofsalmon from two sources, namely
the Credit River (Cr), which runs into Lake
Ontario, and Lake Huron in the region of
Owen Sound (OS). The latter was assumed
to contain low levels ofcontaminants and
was included as a second control in this
study. The fish-containing test diets were
prepared to a constant 20 percent ofpro-
tein using casein as a supplement. There
was one control group (rats fed rat chow
supplemented to 20% with casein) and four
treated groups each consisting of30 females
and 30 males randomly selected and
assigned. Treated animals and their off-
spring received 5.60% (CR), 22.35% (CR),
5.90% (OS) and 23.81% (OS) (wet
weight) fish in their diet. Adult (Fo) rats
received their respective diets for 70 days
prior to mating. The immunology compo-
nent ofthe study consisted ofthree phases.
In phase 1, (Fl generation), pups were
exposed to fish contaminants in utero,
through maternal milk to 21 days ofage,
and through diet to 13 weeks of age.
Immunological testing was initiated at 13
weeks ofage at which time rats were con-
sidered to be immunologically mature. In
phase 2 (reversibility study), F1 generation
pups treated identically to phase 1 pups
were switched to control diet at 13 weeks
of treatment. Pups continued on the con-
trol diet for 3 months. Immunologic tests
were initiated at the end ofthe 3 months.
In phase 3 (F2 generation), treatment of
the F2-generation pups was identical to
that ofFl-generation pups. Immunological
parameters included the enumeration of
PFC numbers, measurement of the NK
cell activity, resistance ofpups to L. mono-
cytogenes infection, and an analysis ofT-
lymphocyte subsets in spleen mononuclear
cell suspensions using flow cytometry.
There was no conclusive evidence that
the fish diets had a measurable effect on
the PFC numbers, the NK cell activity, or
resistance to L. monocytogenes.
There were also no statistically signifi-
cant differences among diets for the T-cell
subsets (p>0.05) except for the F2-genera-
tion males. For these rats there was evi-
dence that in the OS-treated groups the
absolute leukocyte and lymphocyte levels
were higher (p=0.001) than the corre-
sponding levels in the CR treated groups.
This was true also for the T helper (CD4)
subset levels, indicating that the increased
leukocyte numbers in the 5 and 20% OS
groups in comparison to the levels in the
CR groups were due to an increase in the
CD4 subset ofthe T lymphocytes.
ImmunotoxocityStudies in
Nonhuman Primates
The choice ofan appropriate animal model
in which to study the effects of PCBs on
the immune system has been an important
consideration in the process ofevaluating
the magnitude ofrisk which PCBs pose to
human health.
The available limited in vivo and in
vitro data indicate that, in general, metabo-
lism of PCBs in monkeys may be similar
to that in humans (66). While the degree
ofhuman sensitivity to PCBs relative to
that observed in monkeys is not well char-
acterized, the existing phylogenetic and
biologic similarities between humans and
monkeys make the latter a potentially use-
ful animal model in which the immuno-
toxic effects of PCBs can be investigated.
In this respect, the early studies by
Thomas and Hinsdill (46) and Hori et al.
(67) in which the immunotoxic effects of
PCBs were investigated in nonhuman pri-
mates indicated that the monkey might be
more sensitive to the immunotoxic effects
ofPCBs than the rodent.
Following these initial observations, a
series ofpilot studies were designed to test
for toxicity ofAroclor 1254. In the first of
these studies, Aroclor 1254 was given orally
to female cynomolgus monkeys for 238
days at 0.1 mg/kg bw/day (2 monkeys) and
0.4 mg/kg/day (1 monkey). A decreased
antibody response to SRBC was found in
all treated animals compared to controls.
Both monkeys given the 0.1-mg/kg bw/day
dose delivered stillborn infants. The female
treated with 0.4 mg/kg bw/day delivered a
live infant which she nursed. This infant
also failed to respond to SRBC and died at
139 days postpartum with acute confluent
bronchopneumonia (68).
In a second pilot study, Aroclor 1254 at
0.0 or 0.2 mg/kg bw/day (5/7 days) was
given orally to female cynomolgus and rhe-
sus monkeys (4/group); untreated monkeys
served as controls (4/group) (69). The
cynomolgus animals were necropsied after
dosing for 13 months; the rhesus monkeys
were necropsied 15 months after the cyno-
molgus. Terminally, the treated rhesus
monkeys had more severe clinical signs,
higher blood PCB levels, and higher adi-
pose tissue PCB levels than the treated
cynomolgus or the control monkeys. The
IgM (SRBC) titer was lower in treated ani-
mals compared to controls, but statistical
significance was not reached because ofthe
small numbers ofanimals. Rhesus monkeys
were chosen for further work because of
their somewhat greater sensitivity to the
effects ofPCBs (70).
Subsequent to these studies, Tryphonas
et al. (18-20) investigated the effects of
low levels ofAroclor 1254 in adult female
rhesus monkeys exposed to PCBs in utero
and during nursing. In this chronic study,
five groups of female rhesus (M mulatta)
monkeys (16 monkeys/group) were admin-
istered Aroclor 1254 (orally in a capsule
contatining glycerol:corn oil vehicle) at
0.0, 5.0, 20.0, 40.0, or 80.0 pg/kg bw/day.
Immunological effects were reported at 23
months of exposure (18) during which
time a blood PCB pharmacokinetic equi-
librium was established and at 55 months
into the study (19,20). The blood levels of
PCBs noted at 23 months of exposure,
were sustained through to 55 months of
exposure (Table 1).
A statistically significant dose-related
decrease in antibody (IgM and IgG) titers
to SRBC were observed for the primary
response (at 23 months ofexposure) (18)
and for the anamnestic response (at 55
months ofexposure) (19,20). In contrast,
the antibody response to the B-dependent
but T-independent pneumoccocal antigens
was not significantly affected. Alterations
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Table I. Blood PCB levels (Aroclor 1254) in rhesus
monkeys (M. Mulatta).
23 Months, 55 Months,
Test group ppb of PCB ppb of PCB
Control 1 1
5 pg/kg/day 10 10
20 pg/kg/day 30 40
40 pg/kg/day 70 60
80 pg/kg/day 110 120
Data from Tryphonas et al. (18-20).
in T-cell subsets characterized by an
increase in T-suppressor/cytotoxic (CD8)
cells and a reduction in the relative num-
bers ofT-helper/inducer cell (CD4) and in
the CD4/CD8 ratio was also reported in
the high-dose treated group compared to
the control. No effects were noted on total
lymphocytes or B-cells indicating that T-
cell subsets were preferentially affected by
PCBs. However, no treatment-related
effects were noted on the T-lymphocyte
subsets when the analysis was repeated at
55 months of exposure (19). The absence
of detectable effects on the lymphocyte
subpopulations at 55 months into the
study is indicative of the degree ofadapt-
ability of the immune system and empha-
sizes the need for repeated measures ofthe
lymphocyte subsets as the study progresses.
Likewise, a trend towards decreased lev-
els of 3H-thymidine incorporation by
mitogen-induced lymphocyte proliferation
in treated groups were noted only for
PHA-P and ConA but not for the PWM.
In contrast, proliferation to alloantigens
(one-way mixed lymphocyte culture) did
not prove to be a sensitive indicator for
potential effects ofAroclor 1254 on T-cell
function. Repeated measurements of the
total serum immunoglobulin levels (IgG,
IgM, and IgA) and serum protein fractions
also did not prove to be sensitive parame-
ters for effects of low levels of PCBs. A
significant increase ofNK cell activity was
noted in the group of monkeys adminis-
tered the 80 pg/kg doses and only at the
effector:target cell ratio of75:1. To deter-
mine whether interferon, a known modula-
tor of NK activity (71), played a role in
augmenting NK activity, levels of inter-
feron in ConA-stimulated peripheral blood
leukocytes were measured. Results were
inconclusive: a biphasic response was
obtained in which levels were increased for
the 20- and 80-jig/kg bw dose groups but
decreased for the 40-pg/kg bw dose group.
In contrast, serum levels of thymosin
alpha-1, a thymus-derived hormone kn-own
to augment immunologic reactivity in
immunosuppressed mice (71) and to syn-
ergize with interferon to augment NK
activity in mice (72), were significantly
increased in a dose-related fashion.
The mononuclear phagocytic lineage of
cells is important in antigen recognition,
processing, and presentation to T and B
lymphocytes. In this study a trend towards
decreasing phagocytic activity (zymosan)
and phorbol myristate acetate activation of
peripheral blood phagocytic cells (chemilu-
minescence assay) was noted across all
groups (5.0- and 20.0-jg/kg bw groups
were not tested). Similarly, the time to
peak reading ofphorbol myristate acetate
activated phagocytic cells was increased in
the 40- and 80-pg/kg bw groups compared
to the control, indicating that Aroclor
1254 may have affected the functional
integrity ofthe phagocytic cells. However,
interleukin-1 and tumor necrosis factor
levels were not affected substantially by
PCB treatment.
A statistically significant dose-response
increase in total serum complement activity
(CH50) was also observed at 55 months of
exposure. These observations are in agree-
ment with previous results which indicated
that complement levels were increased in
children exposed to TCDD (73) and in
mice exposed to low levels of 1,2,3,6,7,8-
hexachlorodibenzo-p-dioxin (74). The
mechanism by which Aroclor 1254 and
TCDD modulate serum complement
activity remains to be elucidated.
PCBs at high levels have been shown
to affect the endocrine system of rats
(75); however, serum levels of corti-
costeroids (hydrocortisone) measured
throughout the monkey study were not
affected by treatment (76). This clearly
indicates that the observed PCB effects on
several ofthe immune parameters resulted
from a direct effect ofAroclor 1254 on
the immune system.
Human Studies
Population studies by Humphrey (12) and
Kreiss (77) indicated that for the general
population, fish consumption is the major
source of exposure to PCBs. Mean serum
PCB levels of 73-ng/ml (range of 25 to
366 ng/ml) were reported for humans
who consumed on the average 24 lb/year
of fish from Lake Michigan (12). Also,
the geometric mean for PCB levels in sera
from a fish-eating population in Triana,
Alabama, was 17.2 ng/ml (range of 3.2 -
158 ng/ml) with an arithmetic mean of
22.2 ng/,ml (77). Excludtng occupational
exposure, these levels are much higher
than the levels ofPCB found in the general
North American population, which are
normally less than 10 ng/ml (77).
The effects of chemicals on the
immune system ofbreast-fed infants whose
mothers consumed contaminated Great
Lakes fish have been examined in the
maternal-infant cohort epidemiologic
studies ofSmith et al. (78) (the Wisconsin
study) and Humphrey (12) (the Michigan
study). The results ofthese epidemiologic
studies summarized by Swain (79) indi-
cated that the maternal serum PCB level
during pregnancy was positively associated
with the number and type ofinfectious ill-
nesses suffered by the infant during the
first 4 months oflife and that the majority
of infections were of bacterial origin. The
incidence of infections of microbial etiol-
ogy correlated strongly with the highest
rate offish consumption (at least 3 times
per month for 3 years) and with the
cumulative lifetime fish consumption levels.
Similar effects of PCBs on breast-feed-
ing infants were also reported by Hara (80).
These infants were born to women exposed
to Kanechlor 500 (chlorine content, 55%)
and Kanechlor 300 (chlorine content, 43%)
while working in a capacitor factory in
Shiga Prefecture, near Lake Biwa, Japan.
The level ofPCBs in breast milkwere 30 to
200 ppb, which correlated strongly with
blood PCB levels. A higher incidence of
colds and gastrointestinal (vomiting,
abdominal pain) and dermatological
(eczema, itchy skin) manifestations were
observed in breast-feeding infants born to
the PCB-exposed women than in those
infants born to nonexposed women. The
incidence ofthese symptoms increased with
increasing length ofbreast-feeding; however
functional aspects of the immune system
were not investigated in these children.
A recently completed human study by
Svensson et al. (81) reported that con-
sumption offatty fish species, like salmon
and herring, from the Baltic sea had a pro-
found effect on the natural killer cell activ-
ity ofthese humans compared to a control
nonfish eating population. However, the
clinical significance ofthese findings is not
clear because the presence and incidence of
malignancies or infections were not
reported. Furthermore, data on levels of
PCBs in the blood or fat ofthe population
studied, which would permit correlations
between NK activity and levels of PCBs,
were not included in this study.
Immune alterations of potential bio-
logical significance have been reported in
the Japanese (Yusho) and Taiwanese
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(Yu-Cheng) populations exposed to PCBs,
PCDFs, and PCQs via the ingestion of
contaminated rice oil (82-87). Kuratsune
(85) estimated the total amount ofrice oil
contaminants consumed by the exposed
(Yusho) population to be on the average
633 mg of PCB, 3.4 mg of PCDF, and
596 mg of PCQ, which corresponds
roughly to 157, 0.9, and 148 pg/kg bw/day
for PCB, PCDF, and PCQ, respectively.
At this level ofexposure, the length ofthe
latent period between exposure and onset
of clinical illness was approximately 71
days, with a wide range of20 to 190 days.
PCB levels were also determined in retro-
spective studies of the Yu-Cheng patients
who consumed contaminated rice oil for 3
to 9 months. The PCB levels in the
patients' blood collected at about 9 to 18
months after the onset ofthe disease were
in the range from 10 to 720ppb with a
mean value of38 ppb (87).
The immunological investigations in
these patients are summarized as follows.
Persistent respiratory distress accompanied
by Gram-negative bacilli-infected airways
were observed in about half of the Yu-
Cheng cases examined; however, there was
no evidence ofclinically defined bronchial
asthma or pulmonary emphysema (84). A
significant decrease in serum IgA and IgM
but not IgG was noted at 2 years following
the exposure, but levels returned to normal
after 3 years (85). A statistically significant
reduction in the percent oftotal T lympho-
cytes, apparently due to a reduction in T-
helper cells and enhanced responses of
peripheral blood leukocytes to nonspecific
mitogens PHA, ConA, and PWM, was
observed in the exposedYu-Cheng individu-
als at 1 and 3 years after the onset of the
disease (85,86). The Yusho patients tested
at 14 years after exposure showed a slight
increase in T-helper cells and a slight
decrease in T-suppressor cells (82,85); sta-
tistically significantly reduced numbers of
Yu-Cheng patients, compared to control,
had positive skin test reactivity to streptok-
inase/streptodornase antigen mixture and
to tuberculin antigens tested at 1 (streptok-
inase/streptodornase) and 4 years (tuber-
culin) after exposure (83,86,87). The
percent of patients showing a skin test
response and the size of the response
decreased with increased severity of the
clinically observed PCB-induced dermal
lesions and also with PCB concentrations
in the whole blood (82,83).
In contrast to the Yusho and Yu-Cheng
populations, which were exposed to PCDF
and PCQ in addition to PCBs, the study
by Stark et al. (88) examined 52 individuals
exposed only to PCBs (spill resulting from
a transformer explosion in Syracuse, New
York). Statistically significantly increased
levels in the exposed group compared to
controls (nonexposed individuals) were
found for red blood cells, hemoglobin,
hematocrit, and red blood cell mass but
not for WBC.
Emmett et al. (89,90) compared 55
transformer repairmen (38 currently
exposed and 17 previously exposed to
PCBs) with 56 nonexposed subjects. PCB
exposure, predominantly from Aroclor
1260 and to a lesser extent from exposure
to Aroclor 1242, occurred from air and
contaminated surfaces. Clinical manifesta-
tions typical of PCB poisoning were not
present in these individuals. Likewise, the
proportions ofpositive skin responses to
mumps antigen (92% exposed, 89% con-
trol) and Trichophyton antigens (17%
exposed, 8% control) did not differ signifi-
cantly. The mean diameters of the skin
reactions between the exposed and nonex-
posed subjects to mumps antigen in the
two groups were identical (12.6 mm). Thus
delayed hypersensitivity was not affected.
Lawton et al. (91) compared 194
capacitor manufacturing workers (152
males and 42 females) exposed occupation-
ally to Aroclor 1016 with 41 other workers
that had previously been exposed to
Aroclors 1242 and/or 1254. These were
examined in 1976 and in 1979, 2 years
after discontinuance of PCB use in the
operation. At the two examinations, the
approximate geometric mean serum levels
were 363 ppb (57-2270) for Aroclor 1016
and 68 ppb (12-393) for Aroclor 1242
and 1254, with 5 to 95% ranges of 30
(6-142) and 19 (4-108), respectively. In
the study population, the mean service
duration was 17 years (range 2-35) and the
mean age was 40 years (range 20-65).
Determinations in 1976 showed elevations
in total WBCs associated with decreased
polymorphonuclear cells and increased
lymphocytes, monocytes, and eosinophils.
In 1979 there were marginal increases in
monocytes and eosinophils, but the WBCs
were near normal. The statistical associa-
tion ofserum PCB levels and the monocyte
counts was strong.
Chase et al. (92) investigated 120 male
workers (86 exposed, 15 minimally
exposed, and 19 nonexposed) in a railroad
passenger car and locomotive maintenance
facility where workers were exposed to
PCB-containing transformer fluids for 40
years. The average age of the exposed and
nonexposed populations was 41.4 and 30.7
years, respectively. The average plasma PCB
levels were 33.4 ppb in the exposed group
and 14.2 ppb in the unexposed group. No
effect on serum albumin, globulin, or total
protein was found.
Maroni (93) evaluated 80 electrical
capacitor manufacture workers (40 female,
40 males) exposed to Piralene 3010 (a PCB
mixture with 42% chlorine content) for a
mean of 12 ± 6 years. The mean whole
blood PCB concentration was approxi-
mately 450 pg/kg with a range of 310 to
495 pg/kg. Serum electrophoretic fractions
and blood cell counts were not affected.
Smith et al. (78) examined three
groups ofworkers occupationally exposed
to Aroclor 1242 and Aroclor 1016. The
three groups ofworkers were from an elec-
trical equipment manufacturing plant, a
public utility company, and a private util-
ity company. The geometric mean of
serum PCB concentrations among exposed
workers was 8 to 50 times the community
background levels, which ranged from 11.6
to 12.8 ng/ml (arithmetic mean). No
effects were found on hematological para-
meters (hemoglobin, hematocrit, leuko-
cyte, and differential counts), total serum
protein, and serum albumin.
Finally, Stehr-Green et al. (94) exam-
ined environmentally exposed individuals.
The levels ofPCBs were 10.3 and 8.9 ppb
in males and females, respectively. A direct
relationship of age with serum PCB levels
was evident. There were no investigations
on hematological or other immunological
parameters.
Discussion and Summary
The discipline of immunotoxicology is a
relatively new concept and, unlike toxicity
studies that are based on a set ofwell-
defined toxicologic parameters detailed in
the Organization for Economic Cooperation
and Development guidelines, similar
guidelines for immunotoxicity testing are
only at the developmental stages (27,95).
Furthermore, the concept ofGood Labora-
tory Practices, which is applied to non-
clinical toxicologic studies designed for
regulatory purposes, is a relatively new
concept to the immunotoxicologist. Conse-
quently, there is an apparent lack ofunifor-
mity across the studies with regard to the
animal model used, the choice of para-
meters examined, the number of doses
used, and route and duration ofexposure.
These apparent study deficiencies and the
use of high exposure levels, with the
potential of producing toxicologic effects
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which may have affected the immune
system indirectly, diminish the usefulness
ofthe derived data for regulatory purposes.
However, such studies have generated valu-
able information regarding sensitive targets
for immunotoxicity. This information can
be used in designing multiple dose studies
for immunologic end points and thus
contribute to risk assessment.
Such studies demonstrated that com-
mercially available PCB mixtures investi-
gated alone affect several morphologic and
functional aspects of the immune system
in rodents, rabbits, guinea pigs, and chick-
ens. The degree ofseverity of these effects
varied across the studies and depended on
the route and duration of exposure and
the dose used, the PCB mixture studied,
the species, and the age and sex ofthe ani-
mal. In general, such studies indicated
that the higher chlorinated PCB mixtures
might be more immunotoxic than the
lower chlorinated mixtures.
Investigations on the effects ofPCBs on
serum protein fractions, including the per-
cent serum gammaglobulin fraction and the
numbers ofglobulin-producing plasma cells
in popliteal lymph nodes and in germinal
centers ofthe spleen, have produced incon-
clusive results. Reduced leukocyte and T-
lymphocyte levels in peripheral blood were
reported following exposure to PCBs, while
data regarding the effects of PCBs on total
serum immunoglobulin levels have not been
reported in nonimmunized animals.
No generalizations regarding effects on
the thymus, spleen, and lymph nodes can
be made across species. Decreases in thy-
mus weight were observed in rats but not
in guinea pigs or mice. Spleen weight and
the microscopic structure ofthe spleen and
thymus was not affected in rats, guinea
pigs, or mice. In contrast, dermal and oral
exposure to PCBs resulted in marked
thymic atrophy characterized by loss of
thymic cortical lymphocytes and reduction
of germinal center size in the spleen of
chickens and rabbits. Studies on the in
vitro mitogen-induced responses ofsplenic
mononuclear leukocytes indicated that
PHA-induced leukocyte blastogenic activ-
ity was increased, while no effect was noted
when ConA, STM, or PWM were used.
This suggests that PCBs may affect a
selected subpopulation ofT lymphocytes.
Measurements of the mixed lymphocyte
responses, another in vitro correlate ofcell-
mediated immunity, remained unaffected
by the lower chlorinated biphenyls while
the GVH reaction was only transiently
increased at high doses ofPCB treatment.
In addition to humoral and cell-
mediated immune effects, PCBs have been
shown to affect the function ofthe mono-
nuclear phagocytic lineage ofcells. Func-
tional impairment in PCB-exposed animals
is characterized by reduced phagocytic
activity and clearance ofpathogenic bacte-
ria by the spleen and liver, decreased resis-
tance to viruses, and increased sensitivity
to bacterial endotoxins.
Decreased natural killer cell activity has
been reported for Aroclor 1254. However,
despite the evidence that PCB-induced
immunosuppression impairs immune sur-
veillance, Aroclor 1254 was shown to pro-
tect mice and rats (shown as reduced tumor
growth and metastasis) against certain kinds
ofexperimentally induced tumors including
the Ehrlich's tumor ascites and the primary
Walker 256 tumor (43,44). This paradox
points to the need for additional studies on
PCB-induced carcinogenesis.
The existing limited data on the
interactive effects ofPCBs suggest that aro-
matic hydrocarbons that act through the
Ah receptor (96) may have an additive
effect when tested in mixtures, or they may
antagonize the immunotoxic effects of
other chemicals such as dioxins, which are
also present in the Great Lakes. From the
regulatory point ofview, this concept is
significant especially when the magnitude
ofeffects of Great Lakes contaminants on
human health is evaluated, because
any effects on the immune system would
be the resulting net effect of the interac-
tion of all chemicals bioaccumulated in
the tissues offish.
The studies in which fish from the
Great Lakes were used as the source ofmix-
tures ofcontaminants indicated that these
contaminants had an adverse immuno-
modulating effect at least in mice and rats.
However, the difficulties encountered in
defining an appropriate control group for
studies ofthis kind ultimately influence the
interpretation of results. For example, in
the rat studies by Villeneuve et al. (8) and
Chu et al. (64), the Pacific coho salmon
was used as a control. This decision was
based on the observation that the level of
contaminants in this fish was much lower
than that ofthe Lake Ontario coho salmon
(8). However, effects were noted for both
sources ofsalmon. Furthermore, a compari-
son of data from the treated groups to a
control (rat chow) group may not be exper-
imentally meaningful due to the existing
qualitative differences in protein composi-
tion among the various diets. For example,
the mouse studyby Cleland et al. (65) used
a control group ofmice to which all other
results were compared. As expected, statisti-
cally significant reduced immune reactivity
was observed for the Lake Ontario coho
salmon compared to the Pacific coho
salmon. However, comparison ofthese data
to the control group of mice may not be
valid because there was no fish protein in
the control diet.
The Great Lakes health effects rat study
by Tryphonas et al. (manuscript in prepa-
ration) tested salmon from two sources-
the Credit River, which runs into Lake
Ontario, and Lake Huron in the region of
Owen Sound. Previous residue analysis
revealed that the Owen Sound fish contain
contaminants qualitatively similar to those
found in Lake Ontario fish but at reduced
concentrations. Consequently, the Owen
Sound fish were included in the study as a
second control (low level of fish contami-
nants) group in addition to the rat chow
control group. The rat chow control group
consisted of rats fed rat chow supple-
mented with casein to a level equal to that
ofthe fish-containing diets.
Preliminary statistical analysis ofavail-
able data indicated that the direction ofthe
observed effects on the immune system was
not always consistent with the presumed
differences in the level of contaminants in
the fish diets. This suggests that factors
such as qualitative and quantitative differ-
ences in fish contaminants and the poten-
tial immunomodulating effects of fish oils
might be influencing the outcome of
effects. Data on the qualitative and quanti-
tative differences in residues found in the
tissues of rats administered the fish diets
will undoubtedly aid in the interpretation
ofthe observed results. Ideally, one should
use a control group exposed to fish diets
derived from a noncontaminated environ-
ment. However, such a source offish is not
easilyfound.
The use of nonhuman primates to
study the effects of PCBs on the immune
system is desirable due to the phylogenetic
and biologic similarities of monkeys to
humans. This allows for extrapolation of
results to the human situation to be made
with a greater degree ofconfidence than
when such extrapolation is made from data
derived using other animal models. A com-
mon finding in all studies employing non-
human primates is that immunization with
SRBC antigens results in reduced antibody
titers in PCB exposed monkeys compared
to controls. This is true also for the chronic
study carried out in rhesus monkeys
whereby low levels ofPCBs (Aroclor 1254)
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were employed. In this study, a statistically
significantly reduced antibody titer to
SRBC was observed at PCB dose levels as
low as 0.005 mg/kg bw/day. A no adverse
effect level was not identified in this study.
However, the potential interactive effects
ofAroclors or mixtures ofPCBs and other
contaminants, which are readily detectable
in the Great Lakes fish, need to be investi-
gated before a holistic evaluation ofthe risk
that these chemicals pose to human health
can be made.
Ideally, any assessment of the magni-
tude ofthe risk that PCBs pose to human
health should be supported by data derived
from studies involving humans exposed to
PCBs either through their occupation or
through the ingestion of contaminated
food, primarily fish. However, the strengths
and advantages to the use of human data
are often outweighed by the inherent study
design weaknesses, often contradictory
results among the different studies, and the
methodological difficulties in determining
actual exposure doses and in establishing
reliable and reproducible dose-response
relationships. Other confounding factors
such as steroids and antibiotics may be
important in epidemiologic studies in
which the effect ofPCBs on mother-infant
cohorts are investigated. It is known that
human breast milk, but not cow's milk,
contains a steroid that inhibits glucuronyl-
transferase activity required for glucuro-
nidation and excretion ofPCB metabolites
(97). Also certain antibiotics, including
novobiocin, are known to noncompeti-
tively inhibit glucuronyltransferase activity
in vitro (97) thus increasing the body's
burden of PCBs and the degree of risk
posed to these infants and children. All
these factors need to be considered in the
design ofepidemiologic studies and more
importantly in the interpretation ofresults
derived from such studies. While these
data limitations present an obstacle to the
establishment of a potential link between
exposure to PCBs and adverse immune
effects, the existing human studies provide
valuable guidance for the design of addi-
tional perspective studies of populations
exposed to PCBs via the consumption of
Great Lakes-derived fish. Determination of
PCB concentrations in blood and fat tis-
sues from humans without occupational
exposure indicates that background levels
average approximately 10 ppb for blood
and 1 ppm for adipose tissue (96). These
levels parallel the levels of PCBs (Aroclor
1254) measured in blood and fat of the
rhesus monkeys exposed to 5 pg/kg bw/day
ofAroclor 1254 in the Tryphonas et al.
studies (18-20) and for which immune
suppression was detected. However, with
the exception ofthe Yusho and Yu-Cheng
studies for which limited immunological
investigations were included in follow-up
studies, functional parameters of the
immune system were not investigated in
any ofthe occupationally exposed cohorts.
Lack ofsuch data necessitates that extrapo-
lation of results derived from the monkey
studies to humans be made with caution.
The observed increased incidence ofbacte-
rial infections in the mother-infant studies
offish-eating cohorts is ofinterest and sug-
gests that the B cell might be affected. Yet
the studies in monkeys and in other experi-
mental animals in which the antibody
response to various exogenous antigens was
reduced suggested that the effect of PCBs
might be at the antigen-presenting cell
level (mononuclear phagocytic lineage of
cells) or at the T-cell level. The changes
observed in the T lymphocyte and their
subsets in the Yusho (84) and Yu-Cheng
(84) studies provide additional support for
this hypothesis.
Future Considerations
Additional studies are required to define
appropriate experimental models in which
sensitive immunologic end points with
biological relevance to the human situation
can be identified; to improve our under-
standing ofthe mechanisms) that might be
operable in PCB-induced immunomodu-
lation; and to standardize experimental
designs, including the choice ofimmuno-
logical assays used in PCB immunotoxicity
studies. Parallel to these requirements,
there is a need to ensure that the principles
of good laboratory practice be imple-
mented and adhered to during the course
ofimmunotoxicity studies.
Further research is required to better
define the potential interaction among PCB
mixtures or among mixtures ofPCBs and
the many other chemicals that accumulate
in fish tissues. This will assist the regulator
in better defining the net immunotoxic
effect produced bythese chemicals.
The effects ofindividual PCB congeners
and of mixtures of PCBs on quantitative
and functional aspects ofthe immune sys-
tem of experimentally treated laboratory
animals and studies on humans exposed to
PCBs, either through their occupation or
through ingestion of contaminated food,
are an important component ofrisk assess-
ment methodology. Few such studies are
available. Regarding the effects of PCBs on
human health, attention should be focused
on those subpopulations who are especially
vulnerable to such effects. These subpopu-
lations would include people whose
immune systems are already immunosup-
pressed either through medication or due to
certain disease states, as well as infants
whose immune systems are still developing
and the aged whose immune systems are
becoming less effective.
Future immunotoxicity studies are
required for those PCB congeners that
tend to persist in the environment for
a long time and which are found in
the blood and tissues ofhighly exposed
population groups.
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